Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CART-EGFR in Advanced Solid Tumors
NCT01869166Phase 2Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- May 2013
- Primary completion
- Dec 2016
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of CAR-T-EGFR in non-small cell lung cancer (NSCLC), colorectal cancer (CRC), ovarian cancer, cholangiocarcinoma (CCA), pancreatic cancer (PC), sponsored by Chinese PLA General Hospital. Status: unknown.
02
Drugs
CAR-T-EGFR
03
Conditions
non-small cell lung cancer (NSCLC)colorectal cancer (CRC)ovarian cancercholangiocarcinoma (CCA)pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT01869166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01869166.